Catalyst
Slingshot members are tracking this event:
AstraZeneca (AZN) earns FDA approval for Qtern for adults with type 2 diabetes who cannot control blood sugar with saxagliptin, dapagliflozin
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Dapagliflozin, Fda Approval, Qtern, Adults With Type 2 Diabetes, Saxagliptin
